{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-046717","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2025-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.264334+00:00","generated_at":"2026-05-22T01:34:21.603362+00:00","sec_items":["3.03","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"ReShape Lifesciences implements 1-for-25 reverse stock split effective May 9, 2025","bullets":["Reverse stock split at 1-for-25 ratio effective at trading open on May 9, 2025; each 25 shares become 1.","Stockholders approved the split at special meeting on April 1, 2025; fractional shares rounded up.","Authorized shares unchanged; proportional adjustments to warrants, options, and convertible preferred.","New CUSIP for post-split common stock is 76090R408."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-046717","json":"https://secwatch.observer/filing/0001104659-25-046717.json","markdown":"https://secwatch.observer/filing/0001104659-25-046717.md","text":"https://secwatch.observer/filing/0001104659-25-046717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925046717/0001104659-25-046717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925046717/tm2514338d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T01:34:21.603362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}